News file for: Pfizer Inc

Baiyunshan Gets CFDA Approval For Generic Viagra

Baiyunshan Gets CFDA Approval For Generic Viagra

The approval of Baiyunshan’s generic Viagra could help it attain market dominance in China’s erectile dysfunction sector.

Pharmaceutical IT Asia Congress To Highlight Digital Healthcare Innovation

Pharmaceutical IT Asia Congress To Highlight Digital Healthcare Innovation

Oxford Global’s Pharmaceutical IT Asia Congress will take place from March 25-26, 2014 in Singapore..

Oral Rheumatoid Arthritis Treatment XELJANZ® Launched In Japan

Oral Rheumatoid Arthritis Treatment XELJANZ® Launched In Japan

Pfizer and Takeda Pharmaceutical have launched their rheumatoid arthritis drug XELJANZ® (tofacitinib citrate) in Japan.

Pfizer To Conduct NSCLC Drug Trial In Asia

Pfizer To Conduct NSCLC Drug Trial In Asia

Pfizer Inc. will conduct a clinical trial of its crizotinib drug, marketed under the trademark Xalkori®, in four Asian countries.

Pfizer, Mylan To Team Up On Generics Business In Japan

Pfizer, Mylan To Team Up On Generics Business In Japan

Pfizer Inc. and Mylan Inc. have signed an agreement to develop, manufacture, distribute, and market generic drugs in Japan.

Pfizer & Hisun Pharma To Jointly Develop Off-Patent Generics In China

Pfizer & Hisun Pharma To Jointly Develop Off-Patent Generics In China

Pfizer Inc. and Zhejiang Hisun Pharmaceutical have agreed to jointly develop, manufacture, and commercialize off-patent pharmaceutical products in China and global markets.

Coalition Aims To Eradicate 10 Neglected Tropical Diseases By 2020

Coalition Aims To Eradicate 10 Neglected Tropical Diseases By 2020

A large coalition of pharmas, governments, and NGOs have announced their goal of eliminating or controlling 10 neglected tropical diseases by 2020.

SFJ Pharma To Conduct Phase III Trial Of Pfizer’s Axitinib Adjuvant Treatment In Asia

SFJ Pharma To Conduct Phase III Trial Of Pfizer’s Axitinib Adjuvant Treatment In Asia

SFJ Pharma Ltd. will conduct a Phase III clinical trial in Asia of Pfizer’s axitinib for the adjuvant treatment of patients at high risk of recurrent renal cell carcinoma following nephrectomy.

Pfizer Animal Health & The Resource Foundation To Train India’s Rural Farmers

Pfizer Animal Health & The Resource Foundation To Train India’s Rural Farmers

Pfizer Animal Health and The Resource Foundation will help to increase the capacity, productivity, and quality of life of rural farmers in India and Latin America.

Pfizer Animal Health & Jilin Guoyuan Announce Animal Vaccine Joint Venture In China

Pfizer Animal Health & Jilin Guoyuan Announce Animal Vaccine Joint Venture In China

Pfizer And Guoyuan have formed a joint venture to expand development, manufacture, and distribution of animal vaccines in China, with an initial focus on swine vaccines.